Actinic Keratosis: The Precancer You Can Catch and Treat Early
Those rough, scaly patches on sun-exposed skin aren't just stubborn dryness. Actinic keratoses are precancers, and noticing them is one of the highest-stakes things skincare can do, the point where 'anti-aging' becomes actual medicine.
Read the preview
From the DermApproved blog, in Skin Cancer and Mole Checks: actinic keratosis, the rough little patch you've probably been moisturizing for years without realizing what it is. Here's the uncomfortable reframe. That scaly spot on your ear, your scalp, the back of your hand? It might not be dry skin at all. It might be a precancer, sitting on the exact line where skincare stops being about looking good and starts being actual medicine. Now the reassuring part, because there is one: this is possibly the most catchable, most treatable, most preventable thing in all of dermatology, if you know the single sense that gives it away. It isn't sight. We'll tell you what it is, how it's treated, and why the boring old sunscreen sermon turns out to be measurably true, at dermapproved.com/blog.
When a 'dry patch' isn't dry skin
Most rough spots on your skin are nothing. But there's one kind that quietly matters more than any serum you'll ever buy: a persistent, scaly, sandpapery patch on skin that's seen decades of sun, the face, ears, scalp, forearms, and backs of the hands. It looks unremarkable, it's often easier to feel than to see, and people moisturize it for years assuming it's dryness. It isn't. It's an actinic keratosis, and it sits on the boundary between a cosmetic concern and a medical one.
This is the topic where skincare stops being about looking good and starts being about catching something early. Actinic keratoses are precancers, and while the vast majority never become anything dangerous, some do, progressing into squamous cell carcinoma, one of the most common skin cancers. The good news running through this entire piece is that AKs are among the most catchable, most treatable, and most preventable problems in all of dermatology. You just have to know they're not dry skin.
What an actinic keratosis actually is
An actinic keratosis is a patch of skin where cumulative ultraviolet radiation has damaged the DNA of keratinocytes, the main cells of the epidermis, causing them to grow abnormally. The result is a rough, scaly, sometimes crusty or slightly raised lesion, often pink, red, tan, or skin-colored, usually a few millimeters across. They're extraordinarily common in sun-exposed populations, with a global prevalence estimated around 14 percent, and they cluster in fair-skinned, older, and heavily sun-exposed people.
The reason they matter is on a spectrum with cancer. Dermatopathologists genuinely debate whether an AK is best called a precancer, an early squamous cell carcinoma, or a marker of a wider problem, a question a review in the field framed exactly that way, as 'precancer, squamous cell carcinoma, or marker of field cancerization?' That ambiguity is the point: an AK is not a benign blemish that occasionally goes rogue, it's the earliest visible step on a continuum that can end in invasive cancer. Treating it seriously isn't paranoia; it's meeting the lesion at the stage where it's easiest to stop.
How to spot one, and why 'field damage' matters
The single most useful diagnostic trick is touch. An actinic keratosis has a characteristic rough, dry, sandpaper texture that you'll often notice with a fingertip before your eyes register anything, and that texture persists no matter how much you moisturize. Ordinary dry skin softens and clears with a good cream; an AK stubbornly stays rough, may feel tender or catch on things, and tends to sit on the highest-sun-exposure real estate. If a scaly patch on your face, ears, scalp, or hands won't go away over weeks, that persistence is the red flag.
Here's the concept that reframes the whole condition: field cancerization. Chronic UV exposure doesn't damage skin one neat spot at a time; it alters a whole region of cells, creating a 'field' of genetically sun-damaged skin from which multiple AKs, and potentially cancers, can arise. This is why a single AK matters less than the pattern. The annual risk of any one lesion progressing to squamous cell carcinoma is low, on the order of a fraction of a percent, and roughly a quarter of individual AKs even regress on their own. But when someone has many lesions across a sun-damaged field, the cumulative risk climbs, and the whole area, not just the visible spots, needs attention. One AK is a lesion; a field of them is a situation. Because AKs share turf with skin cancers, it's also worth knowing the ABCDE warning signs for moles, and our abcde-check tool walks through them so you can distinguish a rough precancer from a mole that warrants urgent evaluation.
Treating them: freeze the spot or treat the field
Treatment splits along the same logic as the diagnosis: you can target individual lesions or treat the whole field. For one or a few discrete AKs, cryotherapy is the workhorse, a dermatologist sprays liquid nitrogen to freeze the lesion, which blisters and sheds over a week or two, taking the abnormal cells with it. It's quick, done in the office, and highly effective for isolated spots.
When the problem is a field rather than a spot, field-directed topical therapy comes in. The best known is 5-fluorouracil cream, a chemotherapy agent applied at home over a couple of weeks that provokes a dramatic, deliberately inflammatory reaction as it destroys sun-damaged cells across the whole treated area. It looks alarming mid-course, red, crusted, raw, but that's the treatment working, and it clears both visible AKs and the invisible ones brewing in the field. Other field options include imiquimod, photodynamic therapy, and newer agents, and a randomized controlled trial confirmed 5-fluorouracil's value not just for clearing existing AKs but for chemoprevention, reducing future lesions. The right choice depends on how many lesions you have and where, which is a conversation for a dermatologist, not a decision to make from a blog. The universal message is simpler: AK treatment is routine, effective, and vastly easier than treating the cancer it's meant to prevent.
Prevention is the same old sermon, and it works
The frustrating, liberating truth about actinic keratoses is that the thing that prevents them is the thing you've been told a thousand times: sun protection. And here the evidence is not hand-waving. A landmark randomized controlled trial in Australia had middle-aged adults use either a broad-spectrum sunscreen or a placebo cream daily over a summer, and the sunscreen group developed significantly fewer new solar keratoses and had more existing ones regress. That's a direct, causal demonstration that daily sunscreen reduces precancer formation, which is about as close to prevention-you-can-measure as dermatology gets.
So the through-line of every skin-cancer conversation lands back on daily broad-spectrum SPF, not as a beauty step but as medicine. A high-protection facial sunscreen like La Roche-Posay Anthelios UV Clear SPF 50 or EltaMD UV Clear Broad-Spectrum SPF 46 worn every day, and for those with serious cumulative damage a robust broad-UVA formula such as La Roche-Posay Anthelios UVMune 400 SPF 50+, is genuine risk reduction, not vanity. Pair it with the obvious behavioral pieces, shade, hats, and not baking in peak sun, which our sun-safety tool lays out. And do the one thing this whole piece is really asking: if you've got a rough patch that won't quit, don't keep moisturizing it and hoping. Get it looked at. Catching an actinic keratosis is one of the rare skincare acts that can genuinely change how a story ends.
Products mentioned
Independently reviewed and scored — the real products behind this piece.
References
- Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization? — Giornale Italiano di Dermatologia e Venereologia, 2009
- 5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial — Journal of Investigative Dermatology, 2017
- Reduction of solar keratoses by regular sunscreen use — New England Journal of Medicine, 1993
Every cited link is verified to resolve to the paper named. Where a source could not be independently confirmed, it is listed without a link rather than pointing you somewhere wrong.
Frequently asked
How is an actinic keratosis different from a dry patch?
Texture and persistence. An actinic keratosis is a rough, sandpapery, scaly spot on sun-exposed skin that you often feel before you see, and crucially it doesn't clear with moisturizer. Ordinary dry skin softens with a good cream; an AK stubbornly stays rough over weeks, which is the signal to get it checked.
Will an actinic keratosis turn into cancer?
Usually not, individually. Any single AK has a low annual chance, a fraction of a percent, of progressing to squamous cell carcinoma, and some regress on their own. But multiple lesions across sun-damaged skin (field cancerization) raise the cumulative risk, which is why AKs are worth treating rather than ignoring.
How are actinic keratoses treated?
Isolated spots are usually frozen off with cryotherapy (liquid nitrogen) in the office. When there are many lesions across a sun-damaged area, field therapies like 5-fluorouracil cream, imiquimod, or photodynamic therapy treat the whole region and help prevent new lesions. A dermatologist chooses based on how many you have and where.
Does sunscreen actually prevent actinic keratoses?
Yes, and it's proven. A randomized controlled trial showed that adults using daily broad-spectrum sunscreen developed significantly fewer new solar keratoses and had more existing ones regress than those using a placebo cream. Daily broad-spectrum SPF is genuine prevention, not just a cosmetic habit.
Where do actinic keratoses usually appear?
On the areas with the most lifetime sun exposure: the face, ears, scalp (especially in balding men), lips, forearms, and backs of the hands. They're most common in fair-skinned, older, and heavily sun-exposed people. A persistent rough patch in these locations deserves a professional look.